 |
|
Fatigue common after myocardial infarction
June 08, 2009Half of all patients who undergo myocardial infarction are experiencing onerous fatigue four months after the infarction. The patients who are most fatigued are those who perceive the infarction as a sign of chronic illness, those who experience the illness as difficult to control, and those who believe that the illness has a large impact on their life. These are the conclusions of a thesis presented at the Sahlgrenska Academy.
Just over 200 persons completed a questionnaire one week after they had experienced an infarction and again four months later. Many of the patients were also interviewed.
Around half of the patients stated that they felt onerous fatigue four months after the infarction. One third of the patients exhibited expressed fatigue, while one fifth also exhibited symptoms of depression.
"Many people experienced the fatigue as new, and different. It was not related to physical effort or a lack of rest; it occurred unpredictably and could not be attributed to any definite cause", says nurse Pia Alsén, author of the thesis.
Improvements in treatment during the acute phase of a myocardial infarction have lead to significantly more patients surviving, and to shorter periods of hospitalisation. However, medical treatment is not sufficient on its own to ensure a good long-term prognosis. Patients must also change their lifestyle, and many of them do not manage to carry out the changes that are needed. Further, some patients do not participate in the rehabilitation programmes that are available.
"The patients' perception of their illness can be crucial in determining whether they benefit from this part of the treatment or not. A better understanding of the patients' perceptions of their illness can enable us to adapt the information individually for each patient, and encourage more patients to enter the follow-up programmes", says Pia Alsén.
More patients perceived their illness to be chronic four months after the infarction.
"The perception that the condition was a chronic one depended on the extent to which the patients reflected over what had happened. Those who were unwilling to examine causes and correlations perceived the infarction as an isolated event", says Pia Alsén.
A further factor that influenced the patients' perceptions of their illness was whether they felt that they could influence the illness themselves, or whether they placed their trust in medication and other external factors. The patients' belief that they could take control of their situation through such measures as changes in lifestyle decreased after four months.
MYOCARDIAL INFARCTION
Approximately 30,000 persons each year receive hospital treatment for myocardial infarction in Sweden. It is the single most common cause of death in the country. Myocardial infarction is nearly always a result of hardening of the coronary arteries, and is often triggered by a blood clot in such an artery.
University of Gothenburg, Sweden
"Many people experienced the fatigue as new, and different. It was not related to physical effort or a lack of rest; it occurred unpredictably and could not be attributed to any definite cause", says nurse Pia Alsén, author of the thesis.
Improvements in treatment during the acute phase of a myocardial infarction have lead to significantly more patients surviving, and to shorter periods of hospitalisation. However, medical treatment is not sufficient on its own to ensure a good long-term prognosis. Patients must also change their lifestyle, and many of them do not manage to carry out the changes that are needed. Further, some patients do not participate in the rehabilitation programmes that are available.
"The patients' perception of their illness can be crucial in determining whether they benefit from this part of the treatment or not. A better understanding of the patients' perceptions of their illness can enable us to adapt the information individually for each patient, and encourage more patients to enter the follow-up programmes", says Pia Alsén.
More patients perceived their illness to be chronic four months after the infarction.
"The perception that the condition was a chronic one depended on the extent to which the patients reflected over what had happened. Those who were unwilling to examine causes and correlations perceived the infarction as an isolated event", says Pia Alsén.
A further factor that influenced the patients' perceptions of their illness was whether they felt that they could influence the illness themselves, or whether they placed their trust in medication and other external factors. The patients' belief that they could take control of their situation through such measures as changes in lifestyle decreased after four months.
MYOCARDIAL INFARCTION
Approximately 30,000 persons each year receive hospital treatment for myocardial infarction in Sweden. It is the single most common cause of death in the country. Myocardial infarction is nearly always a result of hardening of the coronary arteries, and is often triggered by a blood clot in such an artery.
University of Gothenburg, Sweden
Myocardial Infarction Current Events and Myocardial Infarction News RSSSurvival after heart attack improves in younger women
In recent years, women, particularly younger women, experienced larger improvements in hospital mortality after myocardial infarction (MI) than men, according to a study published in the Oct. 26, 2009 issue of Archives of Internal Medicine.
Cost Effectiveness of Blood Pressure Device Evaluated
A study conducted by the University of Rochester Medical Center (URMC) demonstrates that, for certain patient populations, an experimental device that lowers blood pressure may be a cost effective treatment. The implantable device, called Rheos, is in advanced stages of testing for individuals with drug resistant hypertension.
Drug-eluting stents better than bare-metal stents for heart attack patients
Late-breaking data from the landmark HORIZONS-AMI clinical trial, presented at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, demonstrated that after two years, in heart attack patients, the use of a drug-eluting stent (paclitaxel) was safer and more effective than a bare-metal stent; and that the administration of the anticoagulant medication bivalirudin enhanced safety and efficacy compared to the use of heparin + GPIIb/IIIa inhibitors.
SPIRIT IV trial shows everolimus stent sets new standard for event-free survival
Late-breaking data from SPIRIT IV, a large-scale multi-center study of nearly 4,000 patients in the U.S., shows that an everolimus-eluting stent demonstrated enhanced safety and efficacy in the treatment of de novo native coronary artery lesions when compared to a paclitaxel-eluting stent, and showed that "low late loss" may be achieved with drug-eluting stents without sacrificing safety.
A consistent decline in heart attack rates following the implementation of smoking bans
Strongly enforced legislation to restrict smoking produces rapid and substantial reductions in community rates of heart attack, according to a meta-analysis published today in Circulation, the journal of the American Heart Association.
Pre-hospital organization: The first links in the chain of survival for heart attack patients
Mortality rate following a heart attack has fallen by more than 50% in Europe over the past 25 years. However, because only minor advances in the medical treatment of AMI are expected over the next decade, it is through organisational changes in the pre-hospital phase that mortality rate will continue this decline to below 5%.
Stent for life initiative
Primary angioplasty (with stent implantation) is the most effective therapy for acute myocardial infarction (AMI), but it is not available to many patients, even though most European countries have sufficient resources (ie, catheterisation laboratories) for its wider use.
GERD negatively impacts sleep quality, results in considerable economic burden
There has been much debate about the relationship between gastroesophageal reflux disease (GERD) and sleep.
Results from the Kyoto heart study
The KYOTO HEART Study, which took place in Japan between January 2004 and January 2009, shows that the addition of valsartan to conventional antihypertensive treatment to improve blood pressure control is associated with an improved cardiovascular outcome in Japanese hypertensive patients at high risk of CVD events.
Aspirin works for primary prevention in moderate and high risk diabetics
The beneficial effects of aspirin in primary prevention of cardiovascular events i.e. stroke, MI and cardiac death are known and generally accepted.
More Myocardial Infarction Current Events and Myocardial Infarction News Articles
 |
Myocardial Infarction: An Incredibly Easy! Miniguide by Springhouse (Editor) Pocket-sized guide to risk factors, pathophysiology, prevention, physical examination, diagnostic tests, drug therapy, complications, recovery, patient education, and more. Includes key concepts, quizzes, memory joggers, and color illustrations of pathophysiology. Two-tone format. For nurses. Trim size: 5.5 x 4.5 inches. Softcover. DNLM: Myocardial Infarction Handbooks. |
 |
New Paradigms in the Treatment of Myocardial Infarction (NCME Video 857) Also With: Network for Continuing Medical Education (Primary Contributor), Deepak L. Bhatt (Primary Contributor), Marc S. Sabatine (Primary Contributor) How is the standard of care for patients with MI being redefined in 2005? In these live, interactive dinner forums, two national cardiovascular experts present results from recent clinical trials that may impact future guidelines. Topics include the first major milestone in over a decade for incremental pharmacologic reperfusion and mortality reduction in STEMI; fine points in choosing PCI versus thrombolysis in STEMI; the role of troponins, hs-CRP, and other CV risk markers in targeting therapies in UA/NSTEMI; and interpreting the latest results from drug-eluting stent trials. A community cardiovascular expert from your area will join the national faculty to discuss how to incorporate new evidence-based medicine into actionable critical pathways at your own hospital. Late-breaking... |
|
Adult Acute Myocardial Infarction [VHS] Starring: Aha | |
 |
Myocardial Infarction (Heartbreak) Swamp Dogg (Primary Contributor) |
 |
Prevention of Myocardial Infarction by JoAnn E. Manson (Editor), Paul M. Ridker (Editor), J. Michael Gaziano (Editor), Charles H. Hennekens (Editor) Harvard Medical School, Boston, MA. Clinical research on coronary disease prevention. Chapters on lifestyle modifications, hypertension and hypercholesterolemia, antiplatelet, antioxidant, and estrogen replacement therapies. For health care providers, general internists, and physicians. |
 |
Magnesium Malate 150 mg - 120 VegCapsules by NutraMedix Inc Magnesium is an essential mineral that is required by every cell in the human body and is important for helping to maintain normal cardiovascular, muscle, nerve, bone and cellular function. |
 |
Mini Heart Set Model by Anatomical This Mini Heart Set Model contains 3 hearts. First shows normal heart anatomy. Also has Myocardial Infarction heart demonstrating a partially healed, thinned, and discolored 5 infarcted areas. Includes a thrombus in the apex of the heart. Also contains a heart demonstrating Congestive Heart Failure as a result of hypertension. The left ventricle hypertrophy and the correspondingly enlarged and distorted shape of the heart is shown both internally and externally. All models are approximately 50% actual size. Normal and MI hearts: 4"x 2-1/4"x 1-3/4". CHF: 4"x 2-1/2"x 2-1/4". |
 |
Critical Care Compendium by Mind-Forge Education Services LLC This is a collection of Self Learning Modules and pocket guides. Below are some of the modules and pocket guides in this product. **A quick handy guide to quickly interpret the 12 lead electrocardiogram, identify ischemia, reciprocal changes and to quickly localize a myocardial infarction and involved coronary arteries. **A brief presentation on atrial fibrillation/flutter, optimal monitoring leads, causes and complications related to open heart surgery. **A brief over view of current Advanced Cardiac Life Support treatment algorithms. **ACLS 2006 Code Drugs: Detailed description of 2006 ACLS code drugs and drip charts. (Current for 2007) **A detailed guide to the autonomic nervous system with emphasis placed on parasympathetic and sympathetic involvement and pharmacological... |
 |
New Paradigms in the Treatment of Myocardial Infarction (NCME Video 857) Also With: Network For Continuing Medical Education (Primary Contributor), Deepak L. Bhatt (Primary Contributor), Marc S. Sabatine (Primary Contributor) How is the standard of care for patients with MI being redefined in 2005? In these live, interactive dinner forums, two national cardiovascular experts present results from recent clinical trials that may impact future guidelines. Topics include the first major milestone in over a decade for incremental pharmacologic reperfusion and mortality reduction in STEMI; fine points in choosing PCI versus thrombolysis in STEMI; the role of troponins, hs-CRP, and other CV risk markers in targeting therapies in UA/NSTEMI; and interpreting the latest results from drug-eluting stent trials. A community cardiovascular expert from your area will join the national faculty to discuss how to incorporate new evidence-based medicine into actionable critical pathways at your own hospital. Late-breaking... |
 |
The 12-Lead ECG: In Acute Myocardial Infarction by Tim Phalen (Author) This book reflects the need of EMTs, paramedics, emergency and flight nurses to utilize more sophisticated equipment to assess myocardial infarction, and reduce the damage it does to the heart. This is the first book to focus exclusively on 12-lead interpretation for the prehospital professional. Contents also include the effects of infarction location and coronary occlusion. |
| © 2009 BrightSurf.com |